FrancophonIA/ELRC3.0 huggingface dataset:
English: Viread 123 mg film-coated tablets are indicated in combination with other antiretroviral medicinal products for the treatment of HIV-1 infected paediatric patients, with NRTI resistance or toxicities precluding the use of first line agents, aged 6 to < 12 years who weigh from 17 kg to less than 22 kg.
Danish: Viread 123 mg filmovertrukne tabletter er indiceret i kombination med andre antiretrovirale lægemidler til behandling af hiv 1-inficerede, pædiatriske patienter med NRTI-resistens eller toksiciteter, der udelukker brugen af førstevalgsbehandling, i alderen 6 til < 12 år, der vejer mellem 17 kg og under 22 kg.
English: If your child throws up less than 1 hour after taking Viread, give your child another tablet.
Danish: Hvis Deres barn kaster op mindre end en time efter, at barnet har taget Viread, skal De give
English: Assessment of adverse reactions from HIV-1 clinical study data is based on experience in two studies in 653 treatment-experienced adult patients receiving treatment with tenofovir disoproxil (n = 443) or placebo (n = 210) in combination with other antiretroviral medicinal products for 24 weeks and also in a double-blind comparative controlled study in which 600 treatment-naïve adult patients received treatment with tenofovir disoproxil 245 mg (n = 299) or stavudine (n = 301) in combination with lamivudine and efavirenz for 144 weeks.
Danish: Vurderingen af bivirkninger med data fra kliniske studier med hiv 1-inficerede patienter er baseret på erfaringer fra to studier, hvor 653 behandlingserfarne voksne patienter fik behandling med tenofovirdisoproxil (n = 443) eller placebo (n = 210) i kombination med andre antiretrovirale lægemidler i 24 uger, og ligeledes fra et dobbeltblindt, sammenlignende, kontrolleret studie, hvor 600 behandlingsnaive voksne patienter fik behandling med 245 mg tenofovirdisoproxil (n = 299) eller stavudin (n = 301) i kombination med lamivudin og efavirenz i 144 uger.
English: NAME OF THE MEDICINAL PRODUCT Viread 123 mg film-coated tablets
Danish: Indlægsseddel: Information til brugeren Viread 123 mg filmovertrukne tabletter
English: Bone Mineral Density (BMD) data from Study GS-US-174-0144 are summarized in Table 10:
Danish: Data vedrørende knoglemineraltæthed (BMD) fra studiet GS-US-174-0144 er opsummeret i tabel 10:
English: Viread 163 mg film-coated tablets are supplied in bottles containing 30 tablets.
Danish: Viread 163 mg filmovertrukne tabletter leveres i tabletbeholdere, der indeholder 30 tabletter.
English: Viread 204 mg film-coated tablets Tenofovir disoproxil
Danish: Viread 204 mg filmovertrukne tabletter Tenofovirdisoproxil
English: Viread 123 mg tablets are a treatment for HIV (Human Immunodeficiency Virus) infection.
Danish: Viread 123 mg tabletter anvendes til behandling af infektion med hiv (humant immundefektvirus).
English: • HBV infected children aged 6 to less than 12 years who weigh from 28 kg to less than 35 kg
Danish: • HBV-inficerede børn i alderen 6 til under 12 år, som vejer mellem 28 kg og under 35 kg
English: Viread 204 mg film-coated tablets contain lactose monohydrate.
Danish: Viread 204 mg filmovertrukne tabletter indeholder lactosemonohydrat.
English: • HBV infected children aged 6 to less than 12 years who weigh from 17 kg to less than 22 kg
Danish: • HBV-inficerede børn i alderen 6 til under 12 år, som vejer mellem 17 kg og under 22 kg
English: • Children aged 6 to less than 12 years who weigh from 28 kg to less than 35 kg:
Danish: • børn i alderen 6 til under 12 år • som vejer mellem 28 kg og under 35 kg
English: Viread 204 mg film-coated tablets are supplied in bottles containing 30 tablets.
Danish: Viread 204 mg filmovertrukne tabletter leveres i tabletbeholdere, der indeholder 30 tabletter.
English: What you need to know before your child takes Viread
Danish: Det skal De vide, før Deres barn begynder at tage Viread Giv ikke Viread
English: c 48 weeks of double-blind adefovir dipivoxil followed by 48 weeks open-label tenofovir disoproxil.
Danish: c 48 uger dobbeltblind adefovirdipivoxil, efterfulgt af 48 uger open-label tenofovirdisoproxil.
English: Each Viread tablet contains 245 mg of tenofovir disoproxil (as fumarate).
Danish: Hver Viread-tablet indeholder 245 mg tenofovirdisoproxil (som fumarat).
English: Co-administration of tenofovir disoproxil and didanosine is not recommended (see section 4.4).
Danish: Samtidig administration af tenofovirdisoproxil og didanosin anbefales ikke (se pkt.
English: Viread 123 mg film-coated tablets Tenofovir disoproxil
Danish: Viread 123 mg filmovertrukne tabletter Tenofovirdisoproxil
English: • compensated liver disease and evidence of immune active disease, i.e. active viral replication and persistently elevated serum ALT levels, or histological evidence of moderate to severe inflammation and/or fibrosis.
Danish: • kompenseret leversygdom og tegn på immunaktiv sygdom, dvs. aktiv viral replikation og vedvarende forhøjede ALAT-niveauer i serum eller histologisk tegn på moderat til svær inflammation og/eller fibrose.
English: Please refer to the Summaries of Product Characteristics for Viread 123 mg and 163 mg film-coated tablets for the treatment of HIV-1 infection and chronic hepatitis B in paediatric patients aged 6 to < 12 years weighing 17 kg to < 22 kg and 22 kg to < 28 kg, respectively.
Danish: Se Produktresuméet for Viread 123 mg og 163 mg filmovertrukne tabletter for behandlingen af hiv 1-infektion og kronisk hepatitis B hos pædiatriske patienter i alderen 6 til < 12 år, der vejer hhv. mellem 17 kg og < 22 kg og mellem 22 kg og < 28 kg.
English: Bone Mineral Density (BMD) data from Study GS-US-174-0144 are summarized in Table 9:
Danish: Data vedrørende knoglemineraltæthed (BMD) fra studiet GS-US-174-0144 er opsummeret i tabel 9:
English: • compensated liver disease and evidence of immune active disease, i.e. active viral replication, and persistently elevated serum ALT levels, or histological evidence of moderate to severe inflammation and/or fibrosis.
Danish: • kompenseret leversygdom og tegn på immunaktiv sygdom, dvs. aktiv viral replikation og vedvarende forhøjede ALAT-niveauer i serum eller histologiske tegn på moderat til svær inflammation og/eller fibrose.
English: • Children aged 6 to less than 12 years who weigh from 17 kg to less than 22 kg:
Danish: • børn i alderen 6 til under 12 år • som vejer mellem 17 kg og under 22 kg
English: Bone Mineral Density (BMD) data from Study GS-US-174-0115 are summarized in Table 9:
Danish: Data vedrørende knoglemineraltæthed (BMD) fra studiet GS-US-174-0115 er opsummeret i tabel 9:
English: • HBV infected children aged 6 to less than 12 years who weigh from 22 kg to less than 28 kg
Danish: • HBV-inficerede børn i alderen 6 til under 12 år, som vejer mellem 22 kg og under 28 kg
English: Lumbar spine mean (SD) BMD Z-scorea Lumbar spine mean (SD) change from baseline BMD Z-score a
Danish: BMD Z-resulta ta for columna lumbalis Gennemsnitlig (SD) ændring i BMD Zresultata for columna lumbalis fra baseline n/a n/a
English: • Don't stop any anti-HIV medicines prescribed by your child's doctor when they start Viread if they have both HBV and HIV.
Danish: Deres barns læge, når barnet påbegynder behandlingen med Viread, hvis barnet har både HBV og hiv.
English: Please refer to the Summaries of Product Characteristics for Viread 163 mg and 204 mg film-coated tablets for the treatment of HIV-1 infection and chronic hepatitis B in paediatric patients aged 6 to < 12 years weighing 22 kg to < 28 kg and 28 kg to < 35 kg, respectively.
Danish: Se Produktresuméet for Viread 163 mg og 204 mg filmovertrukne tabletter til behandling af hiv 1-infektion og kronisk hepatitis B hos pædiatriske patienter i alderen 6 til < 12 år, der vejer hhv. mellem 22 kg og < 28 kg og mellem 28 kg og < 35 kg.
English: Steady-state pharmacokinetics of tenofovir were evaluated in 8 HIV-1 infected adolescent patients (aged 12 to < 18 years) with body weight ≥ 35 kg and in 23 HIV-1 infected children aged 2 to < 12 years (see Table 10 below).
Danish: Tenofovir steady-state farmakokinetik blev evalueret hos 8 hiv 1-inficerede unge patienter (i alderen 12 til < 18 år) med kropsvægt ≥ 35 kg og hos 23 hiv 1-inficerede børn i alderen 2 til < 12 år (se tabel 10 nedenfor).
English: HIV-1 clinical studies: Assessment of adverse reactions from HIV-1 clinical study data is based on experience in two studies in 653 treatment-experienced adult patients receiving treatment with tenofovir disoproxil (n = 443) or placebo (n = 210) in combination with other antiretroviral medicinal products for 24 weeks and also in a double-blind comparative controlled study in which 600 treatment-naïve adult patients received treatment with tenofovir disoproxil 245 mg (n = 299) or stavudine (n = 301) in combination with lamivudine and efavirenz for 144 weeks.
Danish: Kliniske studier, hiv 1: Vurderingen af bivirkninger med data fra kliniske studier med hiv 1-inficerede patienter er baseret på erfaringer fra to studier, hvor 653 behandlingserfarne voksne patienter fik behandling med tenofovirdisoproxil (n = 443) eller placebo (n = 210) i kombination med andre antiretrovirale lægemidler i 24 uger, og ligeledes fra et dobbeltblindt, sammenlignende, kontrolleret studie, hvor 600 behandlingsnaive voksne patienter fik behandling med 245 mg tenofovirdisoproxil (n = 299) eller stavudin (n = 301) i kombination med lamivudin og efavirenz i 144 uger.
English: Viread 123 mg film-coated tablets contain lactose monohydrate.
Danish: Viread 123 mg filmovertrukne tabletter indeholder lactosemonohydrat.
English: Each Viread tablet contains 204 mg of tenofovir disoproxil (as fumarate).
Danish: Hver Viread-tablet indeholder 204 mg tenofovirdisoproxil (som fumarat).
English: Administration of 245 mg tenofovir disoproxil every 48 hours can be used based on modelling of single-dose pharmacokinetic data in HIV negative and non-HBV infected subjects with varying degrees of renal impairment, including end-stage renal disease requiring haemodialysis, but has not been confirmed in clinical studies.
Danish: Dette er baseret på modellering af farmakokinetiske data for enkeltdosis hos hiv-negative patienter eller patienter uden HBV-infektion men med forskellige grader af nedsat nyrefunktion, herunder nyresygdom i slutstadiet, hvor det er nødvendigt med dialyse, og er ikke blevet bekræftet i kliniske studier.
English: Contact your child's doctor if your child is outside the permitted weight.
Danish: Deres barn vejer mere eller mindre end den tilladte vægt.
English: l 48 weeks of double-blind tenofovir disoproxil followed by 240 weeks open-label.
Danish: l 48 uger dobbeltblind tenofovirdisoproxil, efterfulgt af 240 uger open-label.
English: dizziness
Danish: udslæt
English: 96b 144e 192g 240i
Danish: 96b 144e 192g 240i 288l 384o 96c 144f
English: Viread 204 mg tablets are also a treatment for chronic hepatitis B, an infection with HBV (hepatitis B virus).
Danish: Viread 204 mg tabletter anvendes også til behandling af kronisk hepatitis B, som er en infektion med HBV (hepatitis B-virus).
English: Viread 163 mg tablets are also a treatment for chronic hepatitis B, an infection with HBV (hepatitis B virus).
Danish: Viread 163 mg tabletter anvendes også til behandling af kronisk hepatitis B, som er en infektion med HBV (hepatitis B-virus).
English: The following side effects are rare (these can affect up to 1 in every 1,000 patients):
Danish: Følgende bivirkninger er sjældne (kan opstå hos mellem 1 og 10 ud af 10.000 patienter):
English: Adjustments of the daily dose of tenofovir disoproxil 33 mg/g granules are recommended in patients with moderate (creatinine clearance 30-49 ml/min) or severe (creatinine clearance < 30 ml/min) renal impairment based on modelling of single-dose pharmacokinetic data in HIV negative and non-HBV infected subjects with varying degrees of renal impairment, including end-stage renal disease requiring haemodialysis.
Danish: Det anbefales at justere den daglige dosis tenofovirdisoproxil 33 mg/g granulat hos patienter med moderat (kreatininclearance 30-49 ml/min) eller svært (kreatininclearance < 30 ml/min) nedsat nyrefunktion.
English: Viread 123 mg film-coated tablets are supplied in bottles containing 30 tablets.
Danish: Viread 123 mg filmovertrukne tabletter leveres i tabletbeholdere, der indeholder 30 tabletter.
English: d 48 weeks double-blind adefovir dipivoxil followed by up to 192 weeks open-label tenofovir disoproxil.
Danish: d 48 uger dobbeltblind adefovirdipivoxil, efterfulgt af op til 192 uger open-label tenofovirdisoproxil.
English: By intent to treat analysis (missing data and switch in antiretroviral therapy (ART) considered as failure), the proportion of patients with HIV-1 RNA below 400 copies/ml and 50 copies/ml at 48 weeks of treatment was 80% and 76% respectively in the tenofovir disoproxil 245 mg arm, compared to 84% and 80% in the stavudine arm. At 144 weeks, the proportion of patients with HIV-1 RNA below 400 copies/ml and 50 copies/ml was 71% and 68% respectively in the tenofovir disoproxil 245 mg arm, compared to 64% and 63% in the stavudine arm.
Danish: I uge 144 var procentdelen af patienter med hiv 1-rna under 400 kopier/ml og 50 kopier/ml henholdsvis 71% og 68% i 245 mg tenofovirdisoproxil-armen sammenlignet med 64% og 63% i stavudinarmen.
English: after the first 4 weeks of treatment, the rate of annual decline post baseline of renal function reported in tenofovir disoproxil treated patients was -1.41 ml/min per year (using Cockcroft-Gault equation) and -0.74 ml/min/1.73 m2 per year (using MDRD equation).
Danish: Efter en indledende reduktion på ca. -4,9 ml/min (ved anvendelse af Cockcroft-Gault-ligningen) eller -3,9 ml/min/1,73 m² (ved anvendelse af modification of diet in renal disease [MDRD]-ligningen) efter de første 4 ugers behandling var hastigheden af den årlige reduktion i nyrefunktionen efter baseline, der blev rapporteret hos patienter behandlet med tenofovirdisoproxil, -1,41 ml/min pr. år (ved anvendelse af Cockcroft-Gault-ligningen) og -0,74 ml/min/1,73 m² pr. år (ved anvendelse af MDRD-ligningen).
English: i 48 weeks of double-blind tenofovir disoproxil followed by 192 weeks open-label.
Danish: i 48 uger dobbeltblind tenofovirdisoproxil, efterfulgt af 192 uger open-label.
English: Suomi/Finland Gilead Sciences Sweden AB Puh/Tel: + 46 (0) 8 5057 1849
Danish: Gilead Sciences Sweden AB Puh/Tel: + 46 (0) 8 5057 1849
English: The increased exposure of tenofovir could potentiate tenofovirassociated adverse events, including renal disorders.
Danish: Den forøgede tenofovir-eksponering kan medføre forstærkede bivirkninger af tenofovirdisoproxil, herunder nyrerelaterede bivirkninger.
English: • Children aged 6 to less than 12 years who weigh from 22 kg to less than 28 kg:
Danish: • børn i alderen 6 til under 12 år • som vejer mellem 22 kg og under 28 kg
English: m 48 weeks of double-blind tenofovir disoproxil followed by 240 weeks open-label.
Danish: m 48 uger dobbeltblind tenofovirdisoproxil, efterfulgt af 240 uger open-label.
English: Each Viread tablet contains 163 mg of tenofovir disoproxil (as fumarate).
Danish: Hver Viread-tablet indeholder 163 mg tenofovirdisoproxil (som fumarat).
English: Please refer to the Summaries of Product Characteristics for Viread 123 mg and 204 mg film-coated tablets for the treatment of HIV-1 infect ion and chronic hepatitis B in paediatric patients aged 6 to < 12 years weighing 17 kg to < 22 kg and 28 kg to < 35 kg, respectively.
Danish: Se Produktresuméet for Viread 123 mg og 204 mg filmovertrukne tabletter til behandling af hiv 1-infektion og kronisk hepatitis B hos pædiatriske patienter i alderen 6 til < 12 år, der vejer hhv. mellem 17 kg og < 22 kg og mellem 28 kg og < 35 kg.
English: Viread 123 mg tablets are also a treatment for chronic hepatitis B, an infection with HBV (hepatitis B virus).
Danish: Viread 123 mg tabletter anvendes også til behandling af kronisk hepatitis B, som er en infektion med HBV (hepatitis B-virus).
English: What Viread is and what it is used for What you need to know before your child takes Viread How to take Viread
Danish: Det skal De vide, før Deres barn begynder at tage Viread Sådan skal Deres barn tage Viread Bivirkninger
English: (log10 copies/ml) HBV DNA (%) < 400 copies/ml (< 69 IU/ml) ALT (%) Normalised ALT
Danish: HBV-dnareduktion fra baselinec (log10 kopier/ml) HBV-dna (%) < 400 kopier/ml (< 69 IE/ml) ALAT (%) Normaliseret ALATd
English: Chronic hepatitis B: In study GS-US-174-0115, 106 HBeAg negative and HBeAg positive patients aged 12 to < 18 years with chronic HBV infection [HBV DNA ≥ 105 copies/ml, elevated serum ALT
Danish: Kronisk hepatitis B: I studie GS-US-174-0115 blev 106 HBeAg-negative og HBeAg-positive patienter i alderen 12 til < 18 år med kronisk HBV-infektion [HBV-dna ≥ 105 kopier/ml, forhøjet serum-ALAT (≥ 2 x ULN) eller en anamnese med forhøjede serum-ALAT-niveauer i løbet af de seneste 24 måneder] behandlet med tenofovirdisoproxil 245 mg (n = 52) eller placebo (n = 54) i 72 uger.
English: g Figures presented are cumulative percentages based upon a Kaplan Meier analysis including data collected after the addition of emtricitabine to open-label tenofovir disoproxil (KM-ITT).
Danish: g De viste tal er kumulative procenter baseret på en Kaplan Meier-analyse, som inkluderer data indsamlet efter tillæg af emtricitabin til open-label tenofovirdisoproxil (KM-ITT).
English: i 48 weeks of double-blind adefovir dipivoxil followed by 144 weeks open-label tenofovir disoproxil.
Danish: i 48 uger dobbeltblind adefovirdipivoxil, efterfulgt af 144 uger open-label tenofovirdisoproxil.
English: Adefovir dipivoxil 10 mg roll over to tenofovir disoproxil 245 mg n = 125d
Danish: 10 mg adefovirdipivoxil skift til 245 mg tenofovirdisoproxil n = 125d
English: h 48 weeks of double-blind adefovir dipivoxil followed by 144 weeks open-label tenofovir disoproxil.
Danish: h 48 uger dobbeltblind adefovirdipivoxil, efterfulgt af 144 uger open-label tenofovirdisoproxil.
English: 96b 144e 192h 240j
Danish: 96b 144e 192h 240j 288m 384o 96c 144f
English: Each Viread tablet contains 123 mg of tenofovir disoproxil (as fumarate).
Danish: Hver Viread-tablet indeholder 123 mg tenofovirdisoproxil (som fumarat).
English: m 48 weeks of double-blind adefovir dipivoxil followed by 240 weeks open-label tenofovir disoproxil.
Danish: m 48 uger dobbeltblind adefovirdipivoxil, efterfulgt af 240 uger open-label tenofovirdisoproxil.
English: Lumbar spine BMD at least 6% decrease b
Danish: Mindst 6% fald i BMD for columna lumbalisb n/a n/a
English: AUC: ↑ 45% Cmax: ↑ 60%
Danish: Cmax: ↑ 55% Cmin: ↑ 52%
English: n 48 weeks of double-blind adefovir dipivoxil followed by 240 weeks open-label tenofovir disoproxil.
Danish: n 48 uger dobbeltblind adefovirdipivoxil, efterfulgt af 240 uger open-label tenofovirdisoproxil.
English: (E421) and silicon dioxide (E551).
Danish: Ethylcellulose (E462) Hydroxypropylcellulose (E463) Mannitol (E421) Siliciumdioxid (E551)
English: + Emtricitabine/Tenofovir disoproxil (200 mg/245 mg q.d.)
Danish: + Emtricitabin/tenofovir disoproxil (200 mg/245 mg q.d.)
English: This is because the active substance in this medicine passes into human breast milk.
Danish: • De må ikke amme, mens De er i behandling med Viread, fordi det aktive stof i denne medicin udskilles i mælken hos mennesker.
English: j 48 weeks of double-blind adefovir dipivoxil followed by 192 weeks open-label tenofovir disoproxil.
Danish: j 48 uger dobbeltblind adefovirdipivoxil, efterfulgt af 192 uger open-label tenofovirdisoproxil.
English: • breakdown of muscle, muscle pain or weakness
Danish: Knogler, led, muskler og bindevæv:
English: If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
Danish: Kontakt lægen, før De tager dette lægemiddel, hvis lægen har fortalt Dem, at De ikke tåler visse sukkerarter.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each scoop delivers one gram of granules which contains 33 mg of tenofovir disoproxil (as fumarate).
Danish: Hver måleske giver ét gram granulat, som indeholder 33 mg tenofovirdisoproxil (som fumarat).
English: Gilead Sciences Netherlands B.V. Tel: + 31 (0) 20 718 36 98
Danish: Gilead Sciences Ltd. Tel: + 44 (0) 8000 113 700
English: HIV-1: Steady-state pharmacokinetics of tenofovir were evaluated in 8 HIV-1 infected adolescent patients (aged 12 to < 18 years) with body weight ≥ 35 kg and in 23 HIV-1 infected children aged 2 to < 12 years (see Table 11 below).
Danish: Hiv 1: Tenofovir steady-state farmakokinetik blev evalueret hos 8 hiv 1-inficerede unge patienter (i alderen 12 til < 18 år) med kropsvægt ≥ 35 kg og hos 23 hiv 1-inficerede børn i alderen 2 til < 12 år (se tabel 11 nedenfor).
English: • flatulence
Danish: • afgang af tarmluft (flatulens)
English: Whole body BMD mean % increase
Danish: Gennemsnitlig stigning (%) i BMD
English: Adefovir dipivoxil 10 mg roll over to tenofovir disoproxil 245 mg n = 90d
Danish: 10 mg adefovirdipivoxil skift til 245 mg tenofovirdisoproxil n = 90d
English: rash
Danish: Lot
English: HIV-1: Steady-state pharmacokinetics of tenofovir were evaluated in 8 HIV-1 infected adolescent patients (aged 12 to < 18 years) with body weight ≥ 35 kg and in 23 HIV-1 infected children aged 2 to < 12 years (see Table 10 below).
Danish: Hiv 1: Tenofovir steady-state farmakokinetik blev evalueret hos 8 hiv 1-inficerede unge patienter (i alderen 12 til < 18 år) med kropsvægt ≥ 35 kg og hos 23 hiv 1-inficerede børn i alderen 2 til < 12 år (se tabel 10 nedenfor).
English: PHARMACEUTICAL FORM AND CONTENTS 30 film-coated tablets.
Danish: 30 filmovertrukne tabletter.
English: The safety of tenofovir disoproxil when used with sofosbuvir/velpatasvir/voxila previr and a pharmacokinetic enhancer (e.g. ritonavir or cobicistat) has not been established.
Danish: Sikkerheden af tenofovirdisoproxil sammen med sofosbuvir/velpatasvir/voxi laprevir og en farmakokinetisk booster (f.eks. ritonavir eller cobicistat) er ikke klarlagt.
English: k 48 weeks of double-blind adefovir dipivoxil followed by 192 weeks open-label tenofovir disoproxil.
Danish: k 48 uger dobbeltblind adefovirdipivoxil, efterfulgt af 192 uger open-label tenofovirdisoproxil.
English: Тел.
Danish: Granulat.
English: l Figures presented are cumulative percentages based upon a Kaplan Meier analysis excluding data collected after the addition of emtricitabine to open-label tenofovir disoproxil (KM-TDF).
Danish: l De viste tal er kumulative procenter baseret på en Kaplan Meier-analyse, som ekskluderer data indsamlet efter tillæg af emtricitabin til open-label tenofovirdisoproxil (KM-TDF).
English: If your child takes more Viread than they should
Danish: Hvis Deres barn har taget for mange Viread
English: Renal impairment
Danish: Normaliseret ALATd
English: Table 6: Efficacy parameters in compensated HBeAg positive patients at week 96, 144, 192, 240, 288 and 384 open-label treatment
Danish: Tabel 6: Virkningsparametre hos kompenserede HBeAg-positive patienter ved uge 96, 144, 192, 240, 288 og 384 open-label-behandling
English: Lumbar spine BMD at least 4% decrease b
Danish: Mindst 4% fald i BMD for columna lumbalisb n/a n/a
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/200/008 30 film-coated tablets EU/1/01/200/009 90 (3 bottles of 30) film-coated tablets
Danish: EU/1/01/200/009 90 (3 tabletbeholdere med 30) filmovertrukne tabletter.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/200/006 30 film-coated tablets EU/1/01/200/007 90 (3 bottles of 30) film-coated tablets
Danish: EU/1/01/200/007 90 (3 tabletbeholdere med 30) filmovertrukne tabletter.
English: What Viread is and what it is used for What you need to know before you take Viread How to take Viread
Danish: Det skal De vide, før De begynder at tage Viread Sådan skal De tage Viread Bivirkninger